In the first portion, hosted by Nina Shah, MD, Professor of Clinical Medicine, Multiple Myeloma Translational Initiative, Division of Hematology-Oncology, University of California San Francisco, San Francisco, California, we discuss treatment options for patients with relapsed/refractory multiple myeloma.
In the second portion (31:00), hosted by Saad Z. Usmani, MD, FACP, Chief of Myeloma Service, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College, New York, New York, we discuss options on the horizon for patients with relapsed/refractory multiple myeloma.
The Multiple Myeloma Research Foundation (MMRF) drives discoveries for new treatments, accelerates groundbreaking clinical trials and fuels the most robust data-driven initiatives in cancer research. Our goal is to find a cure for each and every patient diagnosed with multiple myeloma. Learn more by visiting us at themmrf.org/.
28 апр 2022
